This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Compugen Ltd. Corporation. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Sarah Whelan
Introduction
Sarah Whelan is a prominent inventor based in Mountain View, CA (US). She has made significant strides in the field of biotechnology, particularly in the development of antibody therapies. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Whelan's latest patents focus on triple combination antibody therapies. The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies. This innovative approach aims to enhance the efficacy of cancer treatments by utilizing multiple mechanisms of action.
Career Highlights
Sarah Whelan is currently employed at Compugen Ltd. Corporation, where she continues to push the boundaries of scientific research. Her contributions to the field have been recognized by her peers and the scientific community alike.
Collaborations
Whelan collaborates with talented individuals such as Spencer Liang and Ling Leung, who contribute to her innovative projects. Their teamwork exemplifies the importance of collaboration in achieving groundbreaking results in research and development.
Conclusion
In summary, Sarah Whelan is an influential inventor whose work in triple combination antibody therapies is making a significant impact in the field of biotechnology. Her dedication to innovation and collaboration continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile